Abstract:The genus Streptomyces produces secondary metabolic compounds that are rich in biological activity. Many of these compounds are genetically encoded by large secondary metabolism biosynthetic gene clusters (smBGCs) such as polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS) which are modular and can be highly repetitive. Due to the repeats, these gene clusters can be difficult to resolve using short read next generation datasets and are often quite poorly predicted using standard approaches. We have sequenced the genomes of 13 Streptomyces spp. strains isolated from shallow water and deep-sea sponges that display antimicrobial activities against a number of clinically relevant bacterial and yeast species. Draft genomes have been assembled and smBGCs have been identified using the antiSMASH (antibiotics and Secondary Metabolite Analysis Shell) web platform. We have compared the smBGCs amongst strains in the search for novel sequences conferring the potential to produce novel bioactive secondary metabolites. The strains in this study recruit to four distinct clades within the genus Streptomyces. The marine strains host abundant smBGCs which encode polyketides, NRPS, siderophores, bacteriocins and lantipeptides. The deep-sea strains appear to be enriched with gene clusters encoding NRPS. Marine adaptations are evident in the sponge-derived strains which are enriched for genes involved in the biosynthesis and transport of compatible solutes and for heat-shock proteins. Streptomyces spp. from marine environments are a promising source of novel bioactive secondary metabolites as the abundance and diversity of smBGCs show high degrees of novelty. Sponge derived Streptomyces spp. isolates appear to display genomic adaptations to marine living when compared to terrestrial strains.

Review on the Secondary Metatolites from Phyllospongia Sponges and Their Bioactivities

Spongia Sponges: Unabated Sources of Novel Secondary Metabolites

A Review of Sponge-Derived Diterpenes: 2009–2022

Structurally Unprecedented Metabolites from Marine Sponges

[Advances of Genome and Secondary Metabolism in Streptomyces].

Chemical and biological diversity of new natural products from marine sponges: a review (2009–2018)

Anticancer agents from marine sponges

Secondary metabolites from marine sponges of the genus Agelas : a comprehensive update insight on structural diversity and bioactivity

Studies on Diversity of Sponges-associated Fungi and Their Secondary Metabolites

Bioactive Sesterterpenes and Triterpenes from Marine Sponges: Occurrence and Pharmacological Significance

Secondary Metabolites from Coral-Associated Fungi: Source, Chemistry and Bioactivities

Unusual Secondary Metabolites from the Mangrove Ecosystems: Structures, Bioactivities, Chemical, and Bio-Syntheses

Secondary Metabolites of the Genus Amycolatopsis: Structures, Bioactivities and Biosynthesis

Secondary Metabolites from Fungi Microsphaeropsis spp.: Chemistry and Bioactivities

Anti-Proliferative Potential of Secondary Metabolites from the Marine Sponge Theonella sp.: Moving from Correlation toward Causation

An Update Review of Secondary Metabolites from Marine Fungi.

Recent Advances of Marine Sponge-Associated Microorganisms as a Source of Commercially Viable Natural Products

Cytotoxic Natural Products from Marine Sponge-Derived Microorganisms

Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy.

Diverse and Abundant Secondary Metabolism Biosynthetic Gene Clusters in the Genomes of Marine Sponge Derived Streptomyces spp. Isolates

Recently Discovered Secondary Metabolites from Streptomyces Species